Figure 8From: Treatment of rats with Jiangzhi Capsule improves liquid fructose-induced fatty liver: modulation of hepatic expression of SREBP-1c and DGAT-2Hepatic expression of mRNAs encoding carbohydrate response element binding protein (ChREBP) (a), peroxisome proliferator-activated receptor (PPAR)-γ (b), PPAR-α (c), carnitine palmitoyltransferase (CPT)-1a (d), acyl-CoA oxidase (ACO) (e) and CD36 (f) in water control, fructose control and fructose Jiangzhi Capsule (JZ)-treated rats. Data are means ± SEM (n = 6–9 each group). *P < 0.05. Con control, JZH JZ 100 mg/kg.Back to article page